1. Improving the outcome for children with cancer: development of targeted new agents;Adamson;CA-Cancer J. Clin.,2015
2. Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel;Adema;Int. J. Oncol.,2010
3. Improving nucleoside analogs via lipid conjugation: is fatter any better?;Alexander;Crit. Rev. Oncol. Hemat.,2016
4. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models;Breistøl;Cancer Res.,1999
5. Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts;Bruheim;Anticancer Res.,2013